Trial site
Klinikum Altenburger Land GmbH
- 17running trials
- 5closed trials
The trials here
What the 22 trials at this site are about, from their registry records.
- Conditions
- Stroke11 trials
- Atrial fibrillation4 trials
- Myasthenia gravis4 trials
- Alzheimer disease3 trials
- Acute myeloid leukaemia1 trial
- Mild cognitive impairment1 trial
- Phase
- Phase 310 trials
- Phase 26 trials
- Phase 1/22 trials
- Phase 2/31 trial
- Status
- Recruiting9 trials
- Active, not recruiting4 trials
- Completed4 trials
- Not yet recruiting4 trials
- Terminated1 trial
- Lead sponsor
- argenx3 trials
- Janssen Research & Development, LLC3 trials
- Bayer2 trials
- Biogen2 trials
- Anthos Therapeutics, Inc.1 trial
- and 11 more
Running trials
Not yet recruiting
Recruiting
A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Evaluation of Novel Thrombolytic TGD001 in Patients With Acute Ischemic Stroke
Recruiting
Recruiting
Optimizing Reperfusion to Improve Outcomes and Neurologic Function (ORION)
Recruiting
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
Recruiting
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
Active, not recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Recruiting
Active, not recruiting
Recruiting
Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Stroke6 recruiting
- Myasthenia gravis4 recruiting
- Atrial fibrillation2 recruiting
- Acute myeloid leukaemia1 recruiting
- Alzheimer disease1 recruiting
Closed trials
Completed
Active, not recruiting
Completed
Completed
A Study to Evaluate the Safety and Efficacy of Multiple Doses of LT3001 Drug Product in AIS Subjects
Terminated
Site data: ClinicalTrials.govUpdated 19 Nov 2026